ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Letter to the editor regarding "Development and internal validation of a clinical prediction model for deep surgical site infection after open extremity fractures: the BIGB2OSS score".
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo critically examine the development, internal validation, calibration, and clinical interpretability of the BIGB2OSS score for predicting deep surgical site infection after open extremity fractures.
methodsA focused methodological appraisal was performed using the information reported in the original article. Candidate predictor complexity, event-to-parameter ratio, bootstrap validation, calibration assessment, model specification, and missing outcome data were evaluated against accepted prediction-model principles.
resultsThe model was developed from 45 deep-infection events after examining 18 candidate variables, corresponding to approximately 20 regression parameters (approximately 2.25 events per candidate parameter). Figure 3 reported an expected-to-observed ratio of 1.000, calibration-in-the-large of 0.000, and calibration slope of 1.000; however, these were apparent development-data estimates rather than optimism-corrected calibration measures. The apparent and optimism-adjusted C-statistics were both 0.76 with identical confidence intervals, while it was unclear whether the complete model-building sequence was repeated during bootstrapping. The model intercept and exact score-specific probabilities were not reported. In addition, 138 of 708 otherwise age-eligible patients (19.5%) lacked three-month outcome data.
conclusionThe BIGB2OSS score offers a clinically relevant framework for preliminary risk stratification, but its grouped probabilities should not yet be interpreted as validated individual risks. Full-process bootstrap validation, optimism-corrected calibration, transparent model specification, and sensitivity analyses for missing outcomes are required before external application.
Indexed as
Identifiers
42671615What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.